Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

Health News

Technology Should Be Used More In Neurological Practice

Date: Jun-13-2012
Self-hypnosis for migraines by smart phone, real-time dementia assessment with laptop, epilepsy documentation with home videos: Experts call for recognition of IT innovations in neurology. Smart phone apps for dementia assessment right at a patient's bedside, self-hypnosis programs from mobile phones when migraines strike, detailed 3-D animation of brain and nerve pathways in therapy planning, consistent use of home videos for greater accuracy in epilepsy diagnosis, and e-learning platforms for initial and continuing training with continual self-improvement routines...

Poor Long-Term Physical And Mental Health Suffered By Many Adolescent And Young Adult Cancer Survivors

Date: Jun-13-2012
A new analysis has found that many adolescent and young adult cancer survivors have unhealthy behaviors, chronic medical conditions, a poor quality of life, and significant barriers to health care access. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that greater efforts are needed to provide quality follow-up care to adolescent and young adult cancer survivors and to encourage them to live more healthily...

Pediatric Anxiety Disorders Addressed By Attention Bias Modification Via Computer

Date: Jun-13-2012
According to the Anxiety and Depression Association of America, one in eight children suffers from an anxiety disorder. And because many anxious children turn into severely anxious adults, early intervention can have a major impact on a patient's life trajectory. The understandable reluctance to use psychiatric medications when it comes to children means child psychologists are always searching for viable therapeutic alternatives. Now Prof...

New Therapy Has Potential To Help The Brain As It Reacts To Stroke's Harmful Effects

Date: Jun-13-2012
Researchers at the University of Missouri have demonstrated the effectiveness of a potential new therapy for stroke patients in an article published in the journal Molecular Neurodegeneration. Created to target a specific enzyme known to affect important brain functions, the new compound being studied at MU is designed to stop the spread of brain bleeds and protect brain cells from further damage in the crucial hours after a stroke. Stroke is a leading cause of death in the U.S. with more than 800,000 deaths occurring each year from stroke and other cardiac events...

Control Of HIV Growth May Be Improved By Immune Cells In The Gut

Date: Jun-13-2012
The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut, which the study shows could be an important factor in limiting HIV growth in cells throughout the body...

Avastin Shrinks Tumours - New Research

Date: Jun-13-2012
Patients affected by a form of Neurofibromatosis have seen their tumours shrink dramatically after being treated with the drug Avastin. The latest research, which involved 24 patients in England, has provided remarkable results. The majority of people given the drug as part of the nationally-funded NF2 service have seen significant improvements. Up to 40% of tumours have shrunk, while others which had been growing rapidly stabilised...

Grunenthal To Tackle Unmet Need In Chronic Post-Operative Neuropathic Pain

Date: Jun-13-2012
Grunenthal is planning to commence an international trial, including UK sites, in 2013 to evaluate the effectiveness of Versatis® (5% lidocaine medicated plaster) in the treatment of chronic post-operative neuropathic pain. Chronic pain after surgery can often go undiagnosed, despite its relative prevalence, with 50% of patients suffering pain two years after thoracic surgery1. The double-blind, randomized, placebo-controlled trial is likely to be conducted in several UK centres. Patients will be treated for up to 12 weeks in the clinical trial...

Stem Cell Therapy Shows Prospects For Severe Neurological Diseases

Date: Jun-13-2012
Stem cell therapy: Promising approaches - Neurologists warn about unscrupulous providers According to experts at the Meeting of the European Neurological Society in Prague, current research findings give reason to hope that different types of stem cells could open up new prospects in therapy for severe neurological diseases such as stroke, Parkinson's or MS. But given the many unresolved issues, neurologists warn about dangerous promises of cures from unscrupulous providers...

Stroke Risk Increased By Air Pollution - ENS 2012

Date: Jun-13-2012
Air pollution contributes to higher stroke risk, but socio-cultural factors remain important Air pollution is an important factor in determining the risk of stroke, but concomitant factors should not be underestimated. At the Meeting of the European Neurological Society (ENS) in Prague, researchers from Hungary reported on a comparison of stroke frequency in two districts of Budapest showing that socio-cultural factors also significantly influence the risk of stroke...

Lyxumia® Combined With Insulin Demonstrates Significant HbA1C Reductions And Improvements In Post-Prandial Glucose In Type 2 Diabetes

Date: Jun-13-2012
Phase III GetGoal studies support the need to improve PPG control, independent of FPG levels 1,2,3,4Sanofi announced on Monday that once-daily Lyxumia® (lixisenatide) achieved the primary efficacy endpoint of significantly reducing HbA1c in combination with Lantus® (insulin glargine), with an associated significant reduction in post-prandial glucose (PPG), in patients with uncontrolled Type 2 diabetes (T2DM) on oral anti-diabetics (OADs)...